Home Biosimilar Antibodies Neuronal Signaling Beta Amyloid antibody Solanezumab (Anti-Amyloid Beta) For research use only.
Not for use in humans.

Solanezumab (Anti-Amyloid Beta)

Synonyms: LY2062430

Solanezumab (Anti-Amyloid Beta) is a humanized monoclonal IgG1 antibody targeting the mid-domain of the amyloid-β (Aβ) peptide. It has the potential for the research of Alzheimer’s disease. MW :144.34 KD.

Solanezumab (Anti-Amyloid Beta)

Purity & Quality Control

≥99

Choose Selective Beta Amyloid Inhibitors

Biological Activity

Description Solanezumab (Anti-Amyloid Beta) is a humanized monoclonal IgG1 antibody targeting the mid-domain of the amyloid-β (Aβ) peptide. It has the potential for the research of Alzheimer’s disease. MW :144.34 KD.

Product Details

CAS No. 955085-14-0
Isotype Human IgG1
Source CHO
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Solanezumab (Anti-Amyloid Beta) | Solanezumab (Anti-Amyloid Beta) supplier | purchase Solanezumab (Anti-Amyloid Beta) | Solanezumab (Anti-Amyloid Beta) cost | Solanezumab (Anti-Amyloid Beta) manufacturer | order Solanezumab (Anti-Amyloid Beta) | Solanezumab (Anti-Amyloid Beta) distributor